Allorion Therapeutics is based in Cambridge. It has raised $105M in total funding. Latest round: Series B.
Allorion Therapeutics is based in Cambridge. Allorion Therapeutics has raised $105M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in March 2023. The round record for Allorion Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Qiming Venture Partners, IDG Capital, Longriver Investment Partners, TF Capital, INCE Capital, Firstred Capital and 2 others. 8 distinct backers are named across the disclosed rounds.
We update the Allorion Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026